skip to content

Market News

Puretech notes US patent issue

23 August 2016 07:41

PureTech Health notes the US Patent and Trademark Office (USPTO) has issued a second US Patent to Vedanta Biosciences that broadly covers methods of treating autoimmune disease with mixtures of Clostridium live bacterial strains.

US Patent No. 9,415,079 further expands Vedanta's patent portfolio after the issuance of US Patent No. 9,415,079 on 16 August and earlier issuances in Japan.

The patents are exclusively licensed to Vedanta under an agreement with the University of Tokyo and provide coverage through at least 2031.

Story provided by

Related Company: PRTC

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.